{
    "ticker": "MACI",
    "name": "MediWound Ltd.",
    "description": "MediWound Ltd. is a biotechnology company focused on developing and commercializing innovative therapies for advanced wound care and tissue regeneration. Founded in 2001, the company is headquartered in Yavne, Israel, and has been at the forefront of creating solutions for patients with chronic wounds, burns, and surgical wounds. MediWound's flagship product, NexoBrid, is a topical gel that provides an effective and safe method for the removal of dead tissue in burn wounds, facilitating the healing process. The company is also developing EscharEx, a novel enzyme-based product designed for the debridement of chronic wounds. MediWound's commitment to research and development allows it to leverage cutting-edge science to enhance the standard of care in wound management. With a focus on improving patient outcomes and quality of life, MediWound aims to expand its product offerings and reach more patients worldwide. The company partners with healthcare providers and institutions to ensure that its innovative therapies are accessible to those in need, thus contributing to the advancement of wound care treatments globally.",
    "industry": [
        "Biotechnology",
        "Healthcare"
    ],
    "headquarters": "Yavne, Israel",
    "founded": "2001",
    "website": "https://www.medic wound.com",
    "ceo": "Gal Cohen",
    "social_media": {
        "twitter": "https://twitter.com/MediWound",
        "linkedin": "https://www.linkedin.com/company/mediwound/"
    },
    "investor_relations": "https://ir.mediwound.com",
    "key_executives": [
        {
            "name": "Gal Cohen",
            "position": "CEO"
        },
        {
            "name": "Kfir Golan",
            "position": "CFO"
        }
    ],
    "product_categories": [
        {
            "category": "Wound Care Products",
            "products": [
                "NexoBrid",
                "EscharEx"
            ]
        }
    ],
    "seo": {
        "meta_title": "MediWound Ltd. | Innovative Wound Care Solutions",
        "meta_description": "Discover MediWound Ltd., a leader in biotechnology focused on advanced wound care and tissue regeneration. Explore innovative products like NexoBrid and EscharEx.",
        "keywords": [
            "MediWound",
            "Wound Care",
            "Biotechnology",
            "NexoBrid",
            "EscharEx",
            "Chronic Wounds",
            "Burn Treatment"
        ]
    },
    "faq": [
        {
            "question": "What is MediWound known for?",
            "answer": "MediWound is known for its advanced wound care therapies, particularly NexoBrid and EscharEx."
        },
        {
            "question": "Who is the CEO of MediWound?",
            "answer": "Gal Cohen is the CEO of MediWound Ltd."
        },
        {
            "question": "Where is MediWound headquartered?",
            "answer": "MediWound is headquartered in Yavne, Israel."
        },
        {
            "question": "What are MediWound's main products?",
            "answer": "MediWound's main products include NexoBrid and EscharEx, which are designed for wound debridement."
        },
        {
            "question": "When was MediWound founded?",
            "answer": "MediWound was founded in 2001."
        }
    ],
    "competitors": [
        "AXGN",
        "SYN",
        "OMED"
    ],
    "related_stocks": [
        "JNJ",
        "PFE",
        "ABBV",
        "BMY"
    ]
}